BEIJING and PHILADELPHIA, Jan. 23, 2022 /PRNewswire/ -- Applied Pharmaceutical Science, Inc. ("APS" or "the Company"), has recently announced the Investigational New Drug (IND) application for its ...
CHENGDU, China, Sept. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the 'Company') announced that a new drug application (NDA) for the Company's small molecule rearranged ...
The company submitted data showing A400's efficacy in patients with advanced RET fusion-positive NSCLC in first- or later-line treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback